cabergoline has been researched along with Pituitary Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Colao, A; De Martino, MC; Pivonello, C; Pivonello, R; Simeoli, C | 1 |
| Beccuti, G; Cambria, V; Cicolin, A; Ghigo, E; Grottoli, S; Guaraldi, F; Lopiano, L; Montanaro, E; Natta, G; Prencipe, N; Zibetti, M | 1 |
| Giampietro, A; Iacovazzo, D; Lugli, F | 1 |
| Couldwell, WT; Liu, JK | 1 |
| Gomes, MC; Knoepfelmacher, M; Melo, ME; Mendonca, BB | 1 |
| Bellastella, A; Bellastella, G; Bizzarro, A; Colao, A; Conte, M; Coronella, C; De Bellis, A; Lombardi, G; Pasquali, D; Pivonello, R; Savoia, A; Sinisi, AA | 1 |
2 review(s) available for cabergoline and Pituitary Diseases
| Article | Year |
|---|---|
The dopaminergic control of Cushing's syndrome.
Topics: Adrenal Gland Neoplasms; Cabergoline; Cushing Syndrome; Humans; Hydrocortisone; Pituitary ACTH Hypersecretion; Pituitary Diseases; Pituitary Neoplasms | 2022 |
Contemporary management of prolactinomas.
Topics: Bromocriptine; Cabergoline; Contraindications; Diagnosis, Differential; Ergolines; Female; Humans; Hypophysectomy; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Remission Induction | 2004 |
4 other study(ies) available for cabergoline and Pituitary Diseases
| Article | Year |
|---|---|
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study.
Topics: Behavioral Symptoms; Cabergoline; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Italy; Male; Middle Aged; Pituitary Diseases; Prevalence; Risk Factors; Surveys and Questionnaires | 2021 |
Ectopic posterior pituitary causing hyperprolactinemia.
Topics: Adult; Cabergoline; Choristoma; Diagnosis, Differential; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Oligomenorrhea; Pituitary Diseases; Pituitary Gland, Posterior; Prolactin; Recurrence; Treatment Outcome | 2012 |
Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma.
Topics: Adenoma; Adolescent; Antineoplastic Agents; Cabergoline; Ergolines; Humans; Hypopituitarism; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Prolactin; Prolactinoma; Stroke | 2004 |
Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Cabergoline; Cohort Studies; Dopamine Agonists; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Longitudinal Studies; Male; Pituitary Diseases; Pituitary Function Tests; Pituitary Gland; Seroepidemiologic Studies; Thyroid Hormones; Thyrotropin; Time Factors | 2008 |